Call Options

21 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $1,414 - $1,657
56 Added 16.82%
389 $10,000
Q1 2024

May 07, 2024

BUY
$25.89 - $29.73 $2,847 - $3,270
110 Added 49.33%
333 $9,000
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $862 - $1,120
-33 Reduced 12.89%
223 $6,000
Q3 2023

Nov 02, 2023

BUY
$32.09 - $37.51 $64 - $75
2 Added 0.79%
256 $8,000
Q2 2023

Aug 09, 2023

SELL
$36.12 - $41.79 $722 - $835
-20 Reduced 7.3%
254 $9,000
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $10,792 - $14,050
274 New
274 $11,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $5,470 - $6,677
125 Added 31.33%
524 $39,000
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $744 - $882
-16 Reduced 3.86%
399 $67,000
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $1,738 - $2,154
38 Added 10.08%
415 $82,000
Q4 2021

Feb 07, 2022

SELL
$41.32 - $61.25 $6,156 - $9,126
-149 Reduced 28.33%
377 $151,000
Q3 2021

Oct 28, 2021

BUY
$39.25 - $50.42 $78 - $100
2 Added 0.38%
526 $23,000
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $12,999 - $14,726
362 Added 223.46%
524 $22,000
Q1 2021

May 06, 2021

BUY
$33.49 - $37.77 $401 - $453
12 Added 8.0%
162 $17,000
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $2,677 - $3,404
80 Added 114.29%
150 $3,000
Q3 2020

Nov 06, 2020

BUY
$31.75 - $37.25 $508 - $596
16 Added 29.63%
70 $3,000
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $81 - $115
3 Added 5.88%
54 $1,000
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $97 - $126
-3 Reduced 5.56%
51 $0
Q2 2019

Aug 12, 2019

BUY
$36.98 - $41.52 $184 - $207
5 Added 10.2%
54 $5,000
Q4 2018

Feb 01, 2019

SELL
$38.47 - $43.86 $192 - $219
-5 Reduced 9.26%
49 $11,000
Q3 2018

Nov 09, 2018

BUY
$34.47 - $41.81 $172 - $209
5 Added 10.2%
54 $13,000
Q2 2017

Aug 11, 2017

BUY
N/A
49
49 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.